Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces HSP90 expression and its interaction with hERG.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 172.00 | |
25 mg | In stock | $ 322.00 | |
50 mg | In stock | $ 478.00 | |
100 mg | In stock | $ 688.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 123.00 |
Description | Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG. |
Source |
Molecular Weight | 337.4 |
Formula | C20H19NO4 |
CAS No. | 483-15-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 3.37 mg/mL (10 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydroberberine 483-15-8 Angiogenesis Cytoskeletal Signaling JAK/STAT signaling Membrane transporter/Ion channel Metabolism Tyrosine Kinase/Adaptors HER Potassium Channel HSP inhibit KcsA Inhibitor Heat shock proteins inhibitor